Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial - Jackson, GH; Davies, FE; Pawlyn, C (Lancet Oncol, 2019)